Search

Your search keyword '"Gmeiner WH"' showing total 107 results

Search Constraints

Start Over You searched for: Author "Gmeiner WH" Remove constraint Author: "Gmeiner WH"
107 results on '"Gmeiner WH"'

Search Results

51. Mechanisms of action of FdUMP[10]: metabolite activation and thymidylate synthase inhibition.

52. Unfolding of G-quadruplexes: energetic, and ion and water contributions of G-quartet stacking.

53. A novel polypyrimidine antitumor agent FdUMP[10] induces thymineless death with topoisomerase I-DNA complexes.

54. NMR study of the folding-unfolding mechanism for the thrombin-binding DNA aptamer d(GGTTGGTGTGGTTGG).

55. Novel chemical strategies for thymidylate synthase inhibition.

56. NMR structure of the thrombin-binding DNA aptamer stabilized by Sr2+.

57. Line shape analyses for water 17O NMR quintet observed in a bacteriophage Pf1 solution at different temperatures.

58. Enhanced DNA-directed effects of FdUMP[10] compared to 5FU.

59. Structural basis for topoisomerase I inhibition by nucleoside analogs.

60. Antimetabolite incorporation into DNA: structural and thermodynamic basis for anticancer activity.

61. NMR structure of the 3' stem-loop from human U4 snRNA.

62. Gemcitabine (2',2'-difluoro-2'-deoxycytidine), an antimetabolite that poisons topoisomerase I.

63. Efficacy and safety of FdUMP[10] in treatment of HT-29 human colon cancer xenografts.

64. Energetic and conformational contributions to the stability of Okazaki fragments.

65. The Lown Symposium: The Field of DNA Minor Groove Binders Celebrates the Career of Professor J. William Lown.

66. The structure and dynamics of the U4/U6 snRNP: implications for pre-mRNA splicing and use as a model system to investigate the RNA-mediated effects of (5F)Ura.

67. NMR structure of a gemcitabine-substituted model Okazaki fragment.

68. Effect of 5-FU substitution and mutation on Sm protein binding to human U4 snRNA.

69. Targeted drug delivery to chemoresistant cells: folic acid derivatization of FdUMP[10] enhances cytotoxicity toward 5-FU-resistant human colorectal tumor cells.

70. Molecular dynamics simulation of the human U2B" protein complex with U2 snRNA hairpin IV in aqueous solution.

71. Design, synthesis, and intracellular localization of a fluorescently labeled DNA binding polyamide related to the antibiotic distamycin.

72. Intramolecular binding of a proximal PPII helix to an SH3 domain in the fusion protein SH3Hck : PPIIhGAP.

73. Implications of SH3 domain structure and dynamics for protein regulation and drug design.

74. Structure of the Sm binding site from human U4 snRNA derived from a 3 ns PME molecular dynamics simulation.

75. Antineoplastic activity of a novel multimeric gemcitabine-monophosphate prodrug against thyroid cancer cells in vitro.

76. Shape-selective binding of geometrically-constrained bis-distamycins to a DNA duplex and a model Okazaki fragment of identical sequence.

77. Binding of ethidium to DNA measured using a 2D diffusion-modulated gradient COSY NMR experiment.

78. Dynamics of the Hck-SH3 domain: comparison of experiment with multiple molecular dynamics simulations.

79. Shape-selective recognition of a model Okazaki fragment by geometrically-constrained bis-distamycins.

80. Positive interaction between 5-FU and FdUMP[10] in the inhibition of human colorectal tumor cell proliferation.

81. Increased cytotoxicity and decreased in vivo toxicity of FdUMP[10] relative to 5-FU.

82. Hydrogen exchange shows peptide binding stabilizes motions in Hck SH2.

83. Cytarabine-induced destabilization and bending of a model Okazaki fragment.

84. Cytotoxicity and in-vivo tolerance of FdUMP[10]: a novel pro-drug of the TS inhibitory nucleotide FdUMP.

85. Comparison of SH3 and SH2 domain dynamics when expressed alone or in an SH(3+2) construct: the role of protein dynamics in functional regulation.

86. Effect of cytarabine on the NMR structure of a model okazaki fragment from the SV40 genome.

87. Self-association and backbone dynamics of the hck SH2 domain in the free and phosphopeptide-complexed forms.

88. Cytarabine-induced destabilization of a model Okazaki fragment.

89. Solution structure of the human Hck SH3 domain and identification of its ligand binding site.

90. NMR spectroscopy as a tool to investigate the structural basis of anticancer drugs.

91. Identification and localization of slow, natural, cooperative unfolding in the hematopoietic cell kinase SH3 domain by amide hydrogen exchange and mass spectrometry.

92. Three-dimensional structure of the Hck SH2 domain in solution.

93. Solution structures of 5-fluorouracil-substituted RNA duplexes containing G-U wobble base pairs.

94. Sequential assignment and secondary structure determination for the Src homology 2 domain of hematopoietic cellular kinase.

95. The 5' stem-loop from human U4 snRNA adopts a novel conformation stabilized by G-C and G-U base pairs.

96. Solution structures of 5-fluorouracil-substituted DNA and RNA decamer duplexes.

97. A 3D NOESY-(HCACO)NH experiment for the measurement of NOEs involving 1H alpha in 13C/15N-labeled proteins dissolved in H2O.

99. Improved 3D gd-HCACO and gd-(H)CACO-TOCSY experiments for isotopically enriched proteins dissolved in H2O.

100. Quantum mechanical calculations and experimental measurement of N-terminal charge effects on 1HN and 1HC alpha chemical shifts in peptides.

Catalog

Books, media, physical & digital resources